Director, HTA Value & Evidence — Breast Cancer (Hybrid)

A global pharmaceutical company is seeking a Director for HTA, Value & Evidence focusing on breast cancer, particularly Ibrance. This role will drive strategies for patient access and generate robust evidence for product values. The Director will lead HEOR studies, manage partnerships, and ensure compliance with regulatory guidance, working within a hybrid model requiring onsite presence 2-3 days a week. Candidates should have a relevant graduate degree and substantial experience in health economics and outcomes research. #J-18808-Ljbffr